Rita Axelrod, MD

Contact Dr. Axelrod

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Medical School
New York University School of Medicine - 1970

Residency
Medical College of Georgia

Fellowship
Lankenau Hospital 1975 - 1976
Philadelphia General Hospital

Board Certification
Internal Medicine
Medical Oncology
Hematology

Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital

Hospital Appointment
Active Medical Staff

University Appointment
Professor of Medical Oncology

Research and Clinical Interests
Medical Oncology, Head and Neck Cancers, Lung Cancer, Soft Tissue Sarcoma, Brain Tumor, Esophageal Cancer

Publications

Most recent Peer-reviewed Publications

1. An economic model to value companion diagnostics in non-small-cell lung cancer
2. Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer
3. Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies
4. Endovascular management of carotid blowout
5. A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies
6. A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: A trial of the Eastern Cooperative Oncology Group (E1303)
7. Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma
8. Phase I Trial Using Patupilone (Epothilone B) and Concurrent Radiotherapy for Central Nervous System Malignancies
9. Human papillomavirus and survival of patients with oropharyngeal cancer
10. Introduction: Women and Lung Cancer
11. Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: A phase 2 trial of the eastern cooperative oncology group
12. A randomized phase II study of ixabepilone (BMS-247550) given daily × 5 days every 3 weeks or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: An Eastern Cooperative Oncology Group study
13. Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2
14. Neck dissection followed by chemoradiotherapy for stage IV (N+) oropharynx cancer
15. Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer
16. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group trial 98-01
17. In reply [6]
18. Phase II: Trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy
19. Preliminary report on reduction of esophagitis by amifostine in patients with non-small-cell lung cancer treated with chemoradiotherapy
20. Antiemetic therapy

View All Publications